India Anti Aging Therapeutics Market Analysis

India Anti Aging Therapeutics Market Analysis


$ 3999

India anti-aging therapeutics market is expected to witness growth from $11 Mn in 2022 to $46 Mn in 2030 with a CAGR of 19.53% for the year 2022-2030. The growth from the baby boomer population to the middle age population in India and their subsequent demand for ant-aging products for a more youthful appearance are the major market drivers. The India anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Glenmark, Navitor Pharmaceuticals, and NeuroTrack are some of the key players in the market.

ID: IN10INPH030 CATEGORY: Pharmaceuticals GEOGRAPHY: India AUTHOR: Parul Choudhary

Buy Now Pay via Paypal

India Anti-aging Therapeutics Market Executive Summary

The India anti-aging therapeutics market size is at around $11 Mn in 2022 and is projected to reach $46 Mn in 2030, exhibiting a CAGR of 19.53% during the forecast period. The AYUSH, health and family welfare and finance ministries in India are responsible for allocating the entire Union health funding. For 2023–24, the total budget for health across all three departments is $1.30 Bn. This is slightly less than the planned amount from the previous year, which was approximately $1.4 Bn. But it's crucial to remember that despite this allocated amount in 2022–23 for the health sector, the revised estimate was cut to $112 Bn for the fiscal year 2022–23. All three departments experienced a decrease in funding when comparing the revised estimate to the budgeted estimate: AYUSH by 10%, Health and Family Welfare by 8%, and Finance by 46%. The temporary grant to support the COVID-19 vaccination and the health grant for the 15th Finance Commission was cut, which resulted in a significant decrease in the allocation through the Ministry of Finance in the revised estimate for 2022–23. The government views COVID-19 as a low threat and more than 70% of the Indian populace has received the full COVID-19 vaccination, which is the likely cause.

Every human cell goes through apoptosis, also known as programmed cell death, and is then substituted by brand-new, immature cells. Aging is the process of the body losing its capacity to replace aged cells. The body's inability to repair damaged tissues or organs efficiently, along with an elevated propensity for infections and tumors, are indicators of aging. Human stem cells exhibit extraordinary totipotent and pluripotent characteristics. By assuming the functions of the older cells, these assist in their replacement. These cells can reproduce and replenish themselves; they are not specialized. With the right stimulation, they can produce specialized cells, spanning from muscle cells to brain cells.

The Medical Tourism Corporation collaborates with the world's leading stem cell researchers who purchased this revolutionary equipment in India. The therapy is currently available in Chandigarh, Ahmedabad, and New Delhi. The cost of therapy varies according to factors like the number of sessions, the region of treatment, the patient's condition's severity, etc. The actual expense, however, cannot be ascertained until a medical exam. Regenerative medicine can now assist you in managing the aging process effectively through the use of hormone replacement therapy, PRP Therapy, or stem cells for anti-aging. This is made possible by the most recent technological developments in India. Your body can receive more MSC+ stem cells and stem cell nutrients through MSC+ protocols, which can help treat distressing areas naturally and successfully slow down the aging process. In order to evaluate the quality and effectiveness of stem cells through blood work and lab analysis, enhanced MSC+ therapies typically call for the use of autologous stem cells that are extracted from peripheral blood, adipose tissue, or dental pulp. A combination of cell lineages using mesenchymal cells derived from cord tissue may be necessary for chronic diseases.

India Anti Aging Therapeutics Market

Market Dynamics

Market Growth Drivers Analysis

An increase in life expectancy: As people in India are living longer, there is a greater demand for products that can help to maintain a youthful appearance and delay the onset of age-related conditions. Hence due to the increase in life expectancy, the India Anti-aging Therapeutics market will grow during the forecast period.

Moreover, due to growing awareness of the importance of skincare; there is an increasing awareness among Indian consumers of the importance of taking care of their skin and using products that can help to reduce the appearance of wrinkles and other signs of aging.

Furthermore, as incomes in India continue to rise, more people are able to afford to purchase anti-aging products, which are often more expensive than other types of skincare products. Social media platforms such as Instagram and Facebook have made it easier for companies to market their anti-aging products directly to consumers, which has contributed to the growth of the market. Also, the rise of e-commerce platforms in India has made it easier for consumers to purchase anti-aging products online, further driving the growth of the market.

Market Restraints

Due to limited awareness of the effectiveness of some products, some consumers may be hesitant to purchase anti-aging products due to a lack of awareness about their effectiveness, particularly if the products are not backed by scientific evidence. Moreover, many anti-aging products are relatively expensive, which may make them unaffordable for some consumers. Furthermore, There is limited regulation of the anti-aging market in India, which may make it difficult for consumers to determine the safety and effectiveness of some products.

Competitive Landscape

Key Players

  • Galderma India Private Limited (IND)
  • Dr. Reddy's Laboratories (IND)
  • Cipla (IND)
  • Sun Pharmaceutical Industries (IND)
  • Lupin (IND)
  • Aurobindo Pharma (IND)
  • Zydus Cadila (IND)
  • Torrent Pharmaceuticals (IND)
  • Bharat Biotech (IND)
  • Alkem Laboratories (IND)
  • Glenmark Pharmaceuticals (IND)
  • Pfizer
  • Novartis
  • Roche
  • Merck
  • GlaxoSmithKline
  • AstraZeneca
  • Sanofi
  • Johnson & Johnson
  • Abbott
  • Boehringer Ingelheim

Notable Recent Deals

March 2019: Sun Pharmaceutical Industries acquired a controlling stake in Russia's OAO Tambovskaya Pharmacy Factory, which is a producer of anti-aging Therapeutics.

Healthcare Policies and Regulatory Landscape

Policy changes and Reimbursement scenario of India Anti-aging Therapeutics Market Services

In India, the regulation of pharmaceuticals, including anti-aging products, is primarily the responsibility of the Central Therapeutics Standard Control Organization (CDSCO), which is an agency of the Ministry of Health and Family Welfare. The CDSCO is responsible for approving new Therapeutics and devices, setting standards for the quality, safety, and effectiveness of pharmaceutical products, and monitoring the market to ensure that these products meet the necessary standards.

Anti-aging products that are sold in India must be registered with the CDSCO and must meet the same standards as other pharmaceutical products. This includes demonstrating the safety and effectiveness of the product through clinical trials. In addition, all pharmaceutical products must be labeled with information about their ingredients, uses, and potential side effects.

 

 

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Anti-Aging Therapeutics Market Segmentation

By Product (Revenue, USD Billion):

  • Anti-Wrinkle
  • Hair Color
  • Ultraviolet (UV) Absorption
  • Anti-Stretch Mark
  • Others

By Treatment (Revenue, USD Billion):

  • Hair Restoration
  • Anti-Pigmentation
  • Adult Acne Therapy
  • Breast Augmentation
  • Liposuction
  • Chemical Peel
  • Others

By Target Group (Revenue, USD Billion):

  • Male
  • Female

By Type of Aging (Revenue, USD Billion):

  • Cellular Aging
  • Immune Aging
  • Metabolic Aging
  • Others

By Type of Molecules (Revenue, USD Billion):

  • Biologics
  • Small Molecules

By Mechanism of Action (Revenue, USD Billion):

  • Senolytic
  • Cell Regeneration
  • mTOR inhibitor/Modulator
  • AMP-kinase/AMP Activator
  • Mitochondria Inhibitor/Modulator
  • Others

By Ingredient (Revenue, USD Billion):

  • Retinoid
  • Hyaluronic Acid
  • Alpha Hydroxy Acid
  • Others

By Distribution Channel (Revenue, USD Billion):

  • Pharmacies
  • Stores
  • Online Stores

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.​

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

  • Analyzing historical proprietary data collected from multiple projects.
  • Regularly updating our existing data sets with new findings and trends.
  • Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

  • Searching through academic conferences, published research, citations, and social media platforms
  • Collecting and compiling diverse data to build a comprehensive and detailed database
  • Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

  • Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
  • Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
  • Continuously refreshing our database to ensure that the information remains current and reliable.
  • Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

  • Merging historical data from secondary research with real-time data from primary research.
  • Conducting thorough data validation and cleansing to remove inconsistencies and errors.
  • Organizing data into a structured format that is easily accessible and usable for various applications.
  • Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


Last updated on: 28 March 2023
Updated by: Anish Swaminathan

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up